East Palestine Train Derailment Health Research Program and Liver–Thyroid Health
Official title: The East Palestine Train Derailment Health Research Program
Funded at University of Pittsburgh at Pittsburgh · NIH-11607903 · Data updated 2026-11-12
A patient-facing program to study liver and thyroid health in people affected by the East Palestine train derailment and collect a biospecimen repository for future research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 25, 2025 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $489,001 |
| NIH project number | 3OT2ES038710-01S1 |
| Project ID | NIH-11607903 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals living in the East Palestine area and surrounding communities with potential exposure to derailment-related chemicals.
✕Less likely to help
People without exposure concerns or who are not eligible for participation in the specific cohort may not directly benefit from this study.
What this research studies
This project will enroll people in the East Palestine community to perform liver function tests and thyroid assessments, using FibroScan and standard blood tests. Researchers will also build a biospecimen bank with samples from participants to support future studies. The study emphasizes timely data collection in the first year and coordination with local university partners for phlebotomy and sample handling. Results could help understand how chemical exposures from the derailment may affect liver and thyroid health over time. Participants may contribute samples and health information to advance science relevant to exposure-related health concerns.
Why it matters
Potential benefit: Could improve understanding of how vinyl chloride exposure affects liver and thyroid health and lay groundwork for protective health measures for exposed communities.
How similar studies have gone: Preliminary findings show liver enzyme elevations and abnormal FibroScan results in this community, supporting the relevance of this approach; similar exposure studies have informed health monitoring, though this program is timely and targeted to this event.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Beier, Juliane I — University of Pittsburgh at Pittsburgh
- Study coordinator: Beier, Juliane I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.